Gadolinium-Enhanced Cardiovascular Magnetic Resonance: Administered Dose in Relationship to United States Food and Drug Administration (FDA) Guidelines

Journal of Cardiovascular Magnetic Resonance- United Kingdom

doi 10.1186/1532-429x-14-18

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search